Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1561 entries
Sorted by: Best Match Show Resources per page
High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming.

Journal of medical ultrasonics (2001)

Hasegawa H, Kanai H.
PMID: 27278500
J Med Ultrason (2001). 2011 Jul;38(3):129-40. doi: 10.1007/s10396-011-0304-0. Epub 2011 May 07.

PURPOSE: Echocardiography is a widely used modality for diagnosis of the heart. It enables observation of the shape of the heart and estimation of global heart function based on B-mode and M-mode imaging. Subsequently, methods for estimating myocardial strain...

Cite
Hasegawa H, Kanai H. High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming. J Med Ultrason (2001). 2011;38(3):129-40doi: 10.1007/s10396-011-0304-0.
Hasegawa, H., & Kanai, H. (2011). High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming. Journal of medical ultrasonics (2001), 38(3), 129-40. https://doi.org/10.1007/s10396-011-0304-0
Hasegawa, Hideyuki, and Kanai, Hiroshi. "High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming." Journal of medical ultrasonics (2001) vol. 38,3 (2011): 129-40. doi: https://doi.org/10.1007/s10396-011-0304-0
Hasegawa H, Kanai H. High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming. J Med Ultrason (2001). 2011 Jul;38(3):129-40. doi: 10.1007/s10396-011-0304-0. Epub 2011 May 07. PMID: 27278500.
Copy Download .nbib Format: NLM
Editor's Notes.

Journal of medical ultrasonics (2001)

Kanai H.
PMID: 27279122
J Med Ultrason (2001). 2012 Oct;39(4):293. doi: 10.1007/s10396-012-0395-2.

No abstract available.

Cite
Kanai H. Editor's Notes. J Med Ultrason (2001). 2012;39(4):293doi: 10.1007/s10396-012-0395-2.
Kanai, H. (2012). Editor's Notes. Journal of medical ultrasonics (2001), 39(4), 293. https://doi.org/10.1007/s10396-012-0395-2
Kanai, Hiroshi. "Editor's Notes." Journal of medical ultrasonics (2001) vol. 39,4 (2012): 293. doi: https://doi.org/10.1007/s10396-012-0395-2
Kanai H. Editor's Notes. J Med Ultrason (2001). 2012 Oct;39(4):293. doi: 10.1007/s10396-012-0395-2. PMID: 27279122.
Copy Download .nbib Format: NLM
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma.

Hepatology international

Ogasawara S, Kanai F, Ooka Y, Motoyama T, Suzuki E, Tawada A, Chiba T, Yokosuka O.
PMID: 26201804
Hepatol Int. 2013 Jun;7(2):703-13. doi: 10.1007/s12072-013-9425-4. Epub 2013 Feb 12.

PURPOSE: Sorafenib induces early vascularity reduction in patients with hepatocellular carcinoma (HCC). We sought to identify differences in radiological assessment approaches and to evaluate their usefulness for the prediction of the initial response to sorafenib.METHODS: Forty-eight patients with advanced...

Cite
Ogasawara S, Kanai F, Ooka Y, et al. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatol Int. 2013;7(2):703-13doi: 10.1007/s12072-013-9425-4.
Ogasawara, S., Kanai, F., Ooka, Y., Motoyama, T., Suzuki, E., Tawada, A., Chiba, T., & Yokosuka, O. (2013). Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatology international, 7(2), 703-13. https://doi.org/10.1007/s12072-013-9425-4
Ogasawara, Sadahisa, et al. "Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma." Hepatology international vol. 7,2 (2013): 703-13. doi: https://doi.org/10.1007/s12072-013-9425-4
Ogasawara S, Kanai F, Ooka Y, Motoyama T, Suzuki E, Tawada A, Chiba T, Yokosuka O. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatol Int. 2013 Jun;7(2):703-13. doi: 10.1007/s12072-013-9425-4. Epub 2013 Feb 12. PMID: 26201804.
Copy Download .nbib Format: NLM
Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H.
PMID: 26870193
Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10.

Tumoral cavity formation is a characteristic phenomenon reported in anti-angiogenic therapy in lung lesions. A 57-year-old male with multiple pulmonary metastases from colorectal cancer treated with an oral tyrosine kinase inhibitor, regorafenib, exhibited a characteristic cavity formation after the...

Cite
Kawasaki K, Hamamoto Y, Adachi M, et al. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2015;11(1):231-233doi: 10.3892/ol.2015.3905.
Kawasaki, K., Hamamoto, Y., Adachi, M., Kanai, T., & Takaishi, H. (2016). Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncology letters, 11(1), 231-233. https://doi.org/10.3892/ol.2015.3905
Kawasaki, Kenta, et al. "Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report." Oncology letters vol. 11,1 (2016): 231-233. doi: https://doi.org/10.3892/ol.2015.3905
Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10. PMID: 26870193; PMCID: PMC4727027.
Copy Download .nbib Format: NLM
ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis.

Cell reports

Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S.
PMID: 25683718
Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12.

Ataxia-telangiectasia (A-T) patients occasionally develop diabetes mellitus. However, only limited attempts have been made to gain insight into the molecular mechanism of diabetes mellitus development in A-T patients. We found that Atm

Cite
Takagi M, Uno H, Nishi R, et al. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015;10(6):957-967doi: 10.1016/j.celrep.2015.01.027.
Takagi, M., Uno, H., Nishi, R., Sugimoto, M., Hasegawa, S., Piao, J., Ihara, N., Kanai, S., Kakei, S., Tamura, Y., Suganami, T., Kamei, Y., Shimizu, T., Yasuda, A., Ogawa, Y., & Mizutani, S. (2015). ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell reports, 10(6), 957-967. https://doi.org/10.1016/j.celrep.2015.01.027
Takagi, Masatoshi, et al. "ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis." Cell reports vol. 10,6 (2015): 957-967. doi: https://doi.org/10.1016/j.celrep.2015.01.027
Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12. PMID: 25683718.
Copy Download .nbib Format: NLM
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.

United European gastroenterology journal

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T.
PMID: 27403304
United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13.

BACKGROUND AND AIM: This prospective randomized study was designed to assess the efficacy of 10-day and 14-day rifabutin-based triple therapy as a third- or fourth-line rescue therapy.METHODS: Patients who failed first- and second-line eradication therapy were enrolled. H. pylori...

Cite
Mori H, Suzuki H, Matsuzaki J, et al. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2015;4(3):380-7doi: 10.1177/2050640615618043.
Mori, H., Suzuki, H., Matsuzaki, J., Tsugawa, H., Fukuhara, S., Miyoshi, S., Hirata, K., Seino, T., Matsushita, M., Nishizawa, T., Masaoka, T., & Kanai, T. (2016). Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European gastroenterology journal, 4(3), 380-7. https://doi.org/10.1177/2050640615618043
Mori, Hideki, et al. "Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study." United European gastroenterology journal vol. 4,3 (2016): 380-7. doi: https://doi.org/10.1177/2050640615618043
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13. PMID: 27403304; PMCID: PMC4924440.
Copy Download .nbib Format: NLM
Corticosteroids increase intracellular free sodium ion concentration via glucocorticoid receptor pathway in cultured neonatal rat cardiomyocytes.

International journal of cardiology. Heart & vessels

Katoh D, Hongo K, Ito K, Yoshino T, Kayama Y, Kawai M, Date T, Yoshimura M, Youngs P.
PMID: 29450170
Int J Cardiol Heart Vessel. 2014 Mar 13;3:49-56. doi: 10.1016/j.ijchv.2014.03.001. eCollection 2014 Jun.

BACKGROUND: Glucocorticoids as well as mineralocorticoid have been shown to play essential roles in the regulation of electrical and mechanical activities in cardiomyocytes. Excess of these hormones is an independent risk factor for cardiovascular disease. Intracellular sodium ([NaMETHODS AND...

Cite
Katoh D, Hongo K, Ito K, et al. Corticosteroids increase intracellular free sodium ion concentration via glucocorticoid receptor pathway in cultured neonatal rat cardiomyocytes. Int J Cardiol Heart Vessel. 2014;3:49-56doi: 10.1016/j.ijchv.2014.03.001.
Katoh, D., Hongo, K., Ito, K., Yoshino, T., Kayama, Y., Kawai, M., Date, T., Yoshimura, M., & Youngs, P. (2014). Corticosteroids increase intracellular free sodium ion concentration via glucocorticoid receptor pathway in cultured neonatal rat cardiomyocytes. International journal of cardiology. Heart & vessels, 349-56. https://doi.org/10.1016/j.ijchv.2014.03.001
Katoh, Daisuke, et al. "Corticosteroids increase intracellular free sodium ion concentration via glucocorticoid receptor pathway in cultured neonatal rat cardiomyocytes." International journal of cardiology. Heart & vessels vol. 3 (2014): 49-56. doi: https://doi.org/10.1016/j.ijchv.2014.03.001
Katoh D, Hongo K, Ito K, Yoshino T, Kayama Y, Kawai M, Date T, Yoshimura M, Youngs P. Corticosteroids increase intracellular free sodium ion concentration via glucocorticoid receptor pathway in cultured neonatal rat cardiomyocytes. Int J Cardiol Heart Vessel. 2014 Mar 13;3:49-56. doi: 10.1016/j.ijchv.2014.03.001. eCollection 2014 Jun. PMID: 29450170; PMCID: PMC5801272.
Copy Download .nbib Format: NLM
Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma.

Oncology letters

Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T.
PMID: 28599481
Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21.

Patients with pancreatic ductal adenocarcinoma (PDA) typically succumb to mortality early, even following surgical resection. Therefore, prognostic factors associated with early mortality are required to improve the survival of patients with PDA following surgical resection. Carbohydrate sulfotransferase 15 (CHST15)...

Cite
Ito Z, Takakura K, Suka M, et al. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017;13(6):4799-4805doi: 10.3892/ol.2017.6071.
Ito, Z., Takakura, K., Suka, M., Kanai, T., Saito, R., Fujioka, S., Kajihara, M., Yanagisawa, H., Misawa, T., Akiba, T., Koido, S., & Ohkusa, T. (2017). Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncology letters, 13(6), 4799-4805. https://doi.org/10.3892/ol.2017.6071
Ito, Zensho, et al. "Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma." Oncology letters vol. 13,6 (2017): 4799-4805. doi: https://doi.org/10.3892/ol.2017.6071
Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21. PMID: 28599481; PMCID: PMC5453115.
Copy Download .nbib Format: NLM
Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review.

OncoTargets and therapy

Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F.
PMID: 27051299
Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016.

Lipid-rich carcinoma (LRC) of the breast is a rare breast cancer variant that accounts for

Cite
Oba T, Ono M, Iesato A, et al. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016;9:1641-6doi: 10.2147/OTT.S88726.
Oba, T., Ono, M., Iesato, A., Hanamura, T., Watanabe, T., Ito, T., Kanai, T., Maeno, K., Ito, K., Tateishi, A., Yoshizawa, A., & Takayama, F. (2016). Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. OncoTargets and therapy, 91641-6. https://doi.org/10.2147/OTT.S88726
Oba, Takaaki, et al. "Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review." OncoTargets and therapy vol. 9 (2016): 1641-6. doi: https://doi.org/10.2147/OTT.S88726
Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016. PMID: 27051299; PMCID: PMC4807953.
Copy Download .nbib Format: NLM
True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires.

Nano letters

Anzai H, Suzuki M, Nagashima K, Kanai M, Zhu Z, He Y, Boudot M, Zhang G, Takahashi T, Kanemoto K, Seki T, Shibata N, Yanagida T.
PMID: 28671477
Nano Lett. 2017 Aug 09;17(8):4698-4705. doi: 10.1021/acs.nanolett.7b01362. Epub 2017 Jul 07.

Single crystalline nanowires composed of semiconducting metal oxides formed via a vapor-liquid-solid (VLS) process exhibit an electrical conductivity even without an intentional carrier doping, although these stoichiometric metal oxides are ideally insulators. Suppressing this unintentional doping effect has been...

Cite
Anzai H, Suzuki M, Nagashima K, et al. True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano Lett. 2017;17(8):4698-4705doi: 10.1021/acs.nanolett.7b01362.
Anzai, H., Suzuki, M., Nagashima, K., Kanai, M., Zhu, Z., He, Y., Boudot, M., Zhang, G., Takahashi, T., Kanemoto, K., Seki, T., Shibata, N., & Yanagida, T. (2017). True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano letters, 17(8), 4698-4705. https://doi.org/10.1021/acs.nanolett.7b01362
Anzai, Hiroshi, et al. "True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires." Nano letters vol. 17,8 (2017): 4698-4705. doi: https://doi.org/10.1021/acs.nanolett.7b01362
Anzai H, Suzuki M, Nagashima K, Kanai M, Zhu Z, He Y, Boudot M, Zhang G, Takahashi T, Kanemoto K, Seki T, Shibata N, Yanagida T. True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano Lett. 2017 Aug 09;17(8):4698-4705. doi: 10.1021/acs.nanolett.7b01362. Epub 2017 Jul 07. PMID: 28671477.
Copy Download .nbib Format: NLM
Giant left-sided inguinoscrotal hernia containing the cecum and appendix (giant left-sided Amyand's hernia).

Clinical case reports

Maeda K, Kunieda K, Kawai M, Nagao N, Tanaka C, Oida Y, Kiyama S, Tawada M.
PMID: 25548625
Clin Case Rep. 2014 Dec;2(6):254-7. doi: 10.1002/ccr3.104. Epub 2014 Oct 10.

KEY CLINICAL MESSAGE: The present case involved a 62-year-old male with a large left-sided inguinoscrotal hernia. A CT scan and a clinical examination led to a diagnosis of a giant left-sided Amyand's hernia. The hernia was repaired using the...

Cite
Maeda K, Kunieda K, Kawai M, et al. Giant left-sided inguinoscrotal hernia containing the cecum and appendix (giant left-sided Amyand's hernia). Clin Case Rep. 2014;2(6):254-7doi: 10.1002/ccr3.104.
Maeda, K., Kunieda, K., Kawai, M., Nagao, N., Tanaka, C., Oida, Y., Kiyama, S., & Tawada, M. (2014). Giant left-sided inguinoscrotal hernia containing the cecum and appendix (giant left-sided Amyand's hernia). Clinical case reports, 2(6), 254-7. https://doi.org/10.1002/ccr3.104
Maeda, Kenichi, et al. "Giant left-sided inguinoscrotal hernia containing the cecum and appendix (giant left-sided Amyand's hernia)." Clinical case reports vol. 2,6 (2014): 254-7. doi: https://doi.org/10.1002/ccr3.104
Maeda K, Kunieda K, Kawai M, Nagao N, Tanaka C, Oida Y, Kiyama S, Tawada M. Giant left-sided inguinoscrotal hernia containing the cecum and appendix (giant left-sided Amyand's hernia). Clin Case Rep. 2014 Dec;2(6):254-7. doi: 10.1002/ccr3.104. Epub 2014 Oct 10. PMID: 25548625; PMCID: PMC4270705.
Copy Download .nbib Format: NLM
Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production.

Frontiers in microbiology

Kanai T, Simons JR, Tsukamoto R, Nakajima A, Omori Y, Matsuoka R, Beppu H, Imanaka T, Atomi H.
PMID: 26379632
Front Microbiol. 2015 Aug 26;6:847. doi: 10.3389/fmicb.2015.00847. eCollection 2015.

The hyperthermophilic archaeon Thermococcus kodakarensis can utilize sugars or pyruvate for growth. In the absence of elemental sulfur, the electrons via oxidation of these substrates are accepted by protons, generating molecular hydrogen (H2). The hydrogenase responsible for this reaction...

Cite
Kanai T, Simons JR, Tsukamoto R, et al. Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production. Front Microbiol. 2015;6:847doi: 10.3389/fmicb.2015.00847.
Kanai, T., Simons, J. R., Tsukamoto, R., Nakajima, A., Omori, Y., Matsuoka, R., Beppu, H., Imanaka, T., & Atomi, H. (2015). Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production. Frontiers in microbiology, 6847. https://doi.org/10.3389/fmicb.2015.00847
Kanai, Tamotsu, et al. "Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production." Frontiers in microbiology vol. 6 (2015): 847. doi: https://doi.org/10.3389/fmicb.2015.00847
Kanai T, Simons JR, Tsukamoto R, Nakajima A, Omori Y, Matsuoka R, Beppu H, Imanaka T, Atomi H. Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production. Front Microbiol. 2015 Aug 26;6:847. doi: 10.3389/fmicb.2015.00847. eCollection 2015. PMID: 26379632; PMCID: PMC4549637.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1561 entries